Skip to main content
. 2019 Sep 26;12(4):146. doi: 10.3390/ph12040146

Figure 17.

Figure 17

Schematic representation of niosome formulations based on a cationic aminolipid and the polysorbate 80, also containing the nucleolipid-based Ru(III) complex HoThyRu along with AS1411. On the right, the concentration/effects bar graphs obtained after in vitro treatment on HeLa cancer cells were also reported as representative examples. Figures were adapted from [109].